CVS Health Corporation (LON:0HRS)

London flag London · Delayed Price · Currency is GBP · Price in USD
65.14
-1.21 (-1.83%)
At close: Feb 20, 2025
-14.62%
Market Cap 63.31B
Revenue (ttm) 296.07B
Net Income (ttm) 3.69B
Shares Out n/a
EPS (ttm) 2.92
PE Ratio 17.18
Forward PE n/a
Dividend 2.10 (3.23%)
Ex-Dividend Date Jan 23, 2025
Volume 10,920
Average Volume 48,697
Open 66.54
Previous Close 66.35
Day's Range 65.00 - 66.54
52-Week Range 64.39 - 83.17
Beta 0.61
RSI 66.05
Earnings Date Feb 12, 2025

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1996
Employees 300,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HRS
Full Company Profile

Financial Performance

In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.

Financial numbers in USD Financial Statements

News

CVS Health Stock Gets RS Rating Upgrade

A Relative Strength Rating upgrade for CVS Health shows improving technical performance. Will it continue?

2 days ago - Investor's Business Daily

Thermo Fisher Scientific Elects New Director to Board

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective Feb...

3 days ago - Business Wire

My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys

January saw solid investment activity with $1,500 in net capital added, primarily into Business Development Companies like Owl Rock Capital, Goldman Sachs BDC, and Blackstone Secured Lending Fund. Div...

4 days ago - Seeking Alpha

Top 2 cheap stocks to buy for 2025

The US consumer price index (CPI) was up more than expected in January, raising doubts about the Federal Reserve's ability to lower interest rates further in 2025.

4 days ago - Invezz

High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models

Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health pla...

4 days ago - CNBC

CVS Health Corp Appoints Ed DeVaney as President of CVS Caremark

CVS Health Corp Appoints Ed DeVaney as President of CVS Caremark

5 days ago - GuruFocus

Ed DeVaney named President of CVS Caremark

WOONSOCKET, R.I. , Feb. 17, 2025 /PRNewswire/ -- Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business.

5 days ago - PRNewsWire

Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?

These thirteen large-cap stocks were the best performers in the last week. Are they in your portfolio? Hims & Hers Health, Inc. (NYSE: HIMS) stock escalated 42.12% last week. The stock may have gaine...

6 days ago - Benzinga

3-Stocks to love or leave: Intel, CVS Health, Boeing

Tim Seymour, Seymour Asset Management, joins' Power Lunch' to discuss his plays for three stocks.

8 days ago - CNBC

Prem Watsa's Strategic Moves: CVS Health Corp Takes Center Stage with 7.82% Portfolio Share

Prem Watsa's Strategic Moves: CVS Health Corp Takes Center Stage with 7.82% Portfolio Share

9 days ago - GuruFocus

Wolfe Research Raises CVS Health (CVS) Price Target to $80

Wolfe Research Raises CVS Health (CVS) Price Target to $80

9 days ago - GuruFocus

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock

On Wednesday, CVS Health Corp (NYSE: CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion . Total revenues increased 4.2%, driven by growth in the Health Care...

9 days ago - Benzinga

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock

On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.

9 days ago - Benzinga

CVS shares are up 45% this year here's why it may be starting to turn its business around

Some analysts are more optimistic about CVS' ability to navigate higher-than-expected medical costs in its insurance unit moving forward.

9 days ago - CNBC

CVS wins upgrade to buy as analyst sees more upside potential than its peers

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.

9 days ago - MarketWatch

These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings

CVS Health Corp (NYSE: CVS) reported upbeat earnings for its fourth quarter on Wednesday . The company posted fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Adjusted...

9 days ago - Benzinga

These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings

CVS Health Corp CVS reported upbeat earnings for its fourth quarter on Wednesday.

9 days ago - Benzinga

Reagan's Sugar Quotas, Trump's Tariffs, And The Price Of Protectionism: Here's Why Coke And Pepsi In US Have High Fructose Corn Syrup Instead Of Sugar

The reason U.S. soft drinks primarily use high fructose corn syrup instead of sugar dates back to a trade barrier imposed by former President Ronald Reagan in the 1980s. This policy echoes in today’s ...

9 days ago - Benzinga

This AstraZeneca Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...

10 days ago - Benzinga